Impact Factor 4.019
2017 JCR, Clarivate Analytics 2018

The world's most-cited Microbiology journal

Original Research ARTICLE Provisionally accepted The full-text will be published soon. Notify me

Front. Microbiol. | doi: 10.3389/fmicb.2019.00799

Microbiome on the Bone-Anchored Hearing System: A prospective study

 Tim G. Calon1*,  Margarita Trobos2,  Martin L. Johansson2, 3, Joost van Tongeren1, Malieka van der Lugt-Degen4,  Miranda Janssen1, 5,  Paul H. Savelkoul4, 6, 7,  Robert J. Stokroos1, 8 and  Dries Budding4, 6
  • 1Department of Otorhinolaryngology, Head and Neck Surgery, Maastricht University Medical Center, Netherlands
  • 2Department of Biomaterials, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sweden
  • 3Oticon Medical, Sweden
  • 4IS-Diagnostics Ltd, Netherlands
  • 5Care and Public Health Research Institute, Maastricht University, Netherlands
  • 6Department of Medical Microbiology and Infection Control, Medical Center, VU University Amsterdam, Netherlands
  • 7Department of Medical Microbiology,, NUTRIM School of Nutrition and Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht University, Netherlands
  • 8Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center Utrecht, Netherlands

The bone-anchored hearing system(BAHS) has evolved to a common treatment option for various types of hearing revalidation. The BAHS consists of an implant in the skull that breeches the skin. Soft tissue reactions are a common complication associated with BAHS and are generally poorly understood. This study aims to investigate the influence of BAHS and skin reactions around the implant. A total of 45 patients were prospectively followed from implantation up to at least one year. Swabs were obtained at baseline, 12 weeks follow-up and during cases of inflammation (Holgers score≥2). The microbiota was assessed using IS-pro™, a bacterial profiling method based on the interspace region between the 16S-23S rRNA genes. Detection of operational taxonomic units, the Shannon Diversity Index, sample similarity analyses and Partial Least Squares Discriminant Analysis(PLS-DA) were employed. Staphylococcus epidermidis, Streptococcus pneumoniae/mitis, Propionibacterium acnes, Staphylococcus capitis, Staphylococcus hominis, Bifidobacterium longum, Heamophilus parainfluenzae, Lactobacillus rhamosus, Bordetella spp., Streptococcus sanguinis, Peptostreptococcus anaerobius, Staphylococcus aureus, Lactococcus lactis, Enterobacter cloacae and Citrobacter koseri were the most commonly found bacterial species. Streptococcus pneumoniae/mitis was significantly more often observed
after implantation, whereas Propionibacterium acnes was significantly less observed in the inflamed group than the non-inflamed. The relative abundance of Staphylococcus epidermidis(17%) and Staphylococcus aureus(19.4%) was the highest for the group of patients with inflammation. The Shannon Diversity Index was significantly increased after implantation compared with pre-surgical swabs for Firmicutes, Actinobacteria, Fusobacteria, Verrucomicrobia(FAFV), but not for other phyla. When combining all phyla, there was no significant increase in the Shannon Diversity Index. The diversity index was similar post-surgically for patients experiencing inflammation and for patients without inflammation. With a supervised classifier(PLS-DA), patients prone to inflammation could be identified at baseline with an accuracy of 91.7%. In addition, PLS-DA could classify post-surgical abutments as non-inflamed or inflamed with an accuracy of 97.7%.

This study shows the potential of using IS-pro™ to describe and quantify the microbiota associated with the percutaneous BAHS. Furthermore, the results indicate the possibility of an early identification of patients susceptible to adverse skin reaction following implantation. Both S. aureus and S. epidermidis should be considered as relevant bacteria for BAHS-associated inflammation.

Keywords: Microbiology, biomaterial, microbiome analyses, IS-pro, Bone-anchored devices, bone-anchored hearing aid, Percutaneous implant, Staph aureus, Staphyloccocus, Staphyloccoccus aureus, Staphyloccocus epidermidis, BAHS, BAHI, Holgers scale, Titanium, Soft tissue reaction, Skin microbiome

Received: 27 Aug 2018; Accepted: 28 Mar 2019.

Edited by:

George Tsiamis, University of Patras, Greece

Reviewed by:

Henrik R. Nilsson, University of Gothenburg, Sweden
James D. Bryers, University of Washington, United States  

Copyright: © 2019 Calon, Trobos, Johansson, van Tongeren, van der Lugt-Degen, Janssen, Savelkoul, Stokroos and Budding. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Dr. Tim G. Calon, Department of Otorhinolaryngology, Head and Neck Surgery, Maastricht University Medical Center, Maastricht, Netherlands, tim.calon@catharinaziekenhuis.nl